Related Experiment Video

Updated: Jan 7, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.9K

ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis

Guanyou Huang1, Yigong Wei2, Xiaohong Hou2

  • 1Department of Neurosurgery, The Second People's Hospital of Guiyang (Jinyang Hospital), No. 547 Jinyang South Road, Guanshanhu District, Guiyang, 550081, China. guanyouhuang024410@163.com.

Journal of Neuro-Oncology
|December 22, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ANG-modified exosomesBrain-targeted deliveryBreast cancer brain metastasisFerroptosisGPX4Oleanolic acid

More Related Videos

Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.9K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K

Related Experiment Videos

Last Updated: Jan 7, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.9K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.9K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

Articles linked to this work by shared authors, journal, and citation graph.

Dendrobium officinale polysaccharide ameliorates polycystic ovary syndrome by modulating the MAPK/ERK signaling pathway.

Frontiers in pharmacology·2026

Interleukin-6 Downregulates T Helper 17 Cytokines via Indoleamine 2,3-Dioxygenase 1 at the Maternal-Fetal Interface.

American journal of reproductive immunology (New York, N.Y. : 1989)·2026

Inverse association between peripheral natural killer cells and thyroid autoimmunity in cases of miscarriage: Evidence from a cross-sectional study.

The Journal of international medical research·2026

Pyroptosis in endometritis: Molecular mechanisms, pathogenic roles, and therapeutic opportunities.

iScience·2026

IGF-1 Deficiency Serves as an Integrated Biomarker Pathogenic Driver and Predictor in Poor Ovarian Response.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Comparison of animal models for immune premature ovarian insufficiency.

PeerJ·2025

Volumetric analysis of radiographic changes after stereotactic radiosurgery for treatment of non-responding brain metastases.

Journal of neuro-oncology·2026

Spinal ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes with a focus on the pediatric population (Part III of ependymomas across compartments).

Journal of neuro-oncology·2026

Dose selection and clinical decision-making after Gamma Knife surgery for large brain metastases: implications for early identification of true progression.

Journal of neuro-oncology·2026

Predictive modeling of lung cancer subtype with integration of clinical and thoracic imaging features to guide early brain metastasis management.

Journal of neuro-oncology·2026

Surgical characteristics and postoperative outcomes in a retrospective cohort study of patients with molecularly defined oligodendroglioma.

Journal of neuro-oncology·2026

Early experience with cerebrospinal fluid cell-free DNA molecular profiling in a neuro-oncology practice.

Journal of neuro-oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us